14 Feb 2012 

HOME

Pharma/CDC on Brain damage from vaccines, Fauci, Phages, Bioweapons manufacture

HHS.gov is Incompetent; BMJ calls fraud "crime.")

Official: CFIDS and MS-Lyme are the same disease; Epstein-Barr 


CDC Greed (won't answer the FOIA)

ELISA = arbitrary cutoff.

Disclaimer

Overview
 

TUSKEGEE - By Jerry Leonard

1998, CIA Oilmen & Israelis plan to overthrow Saddam for the oil.

Bush/Gore  Oil/War-(Oct,2000)  

Bush's own explainer (Oct 2000): Iraq Oil

Iraq was an oil-theft war.

Nature 440, 278 (16 March 2006) | doi:10.1038/440278b

Lyme vaccine demonized by advocacy groups
Edward McSweegan1

1692 Barrister Court, Crofton, Maryland 21114, USA


Sir:
As a microbiologist who managed a federal programme on Lyme disease in
the 1990s, I consider that any new clinical trials of a vaccine
candidate based on the protein OspA, as mentioned in your News Feature
"Uphill struggle" (Nature 439, 524-525; 2006), should be confined to
Europe, for three reasons.

First, Lyme disease is non-communicable, readily treatable with common
antibiotics and geographically localized in the United States.
Neurological cases - where treatment can be problematic - are more
common in Europe and a new vaccine may reduce the costs and
consequences of infection.

Second, European experience with the widely used tick-borne
encephalitis virus (TBEV) vaccine may facilitate vaccine-trial
recruitment and greater public acceptance of a new Lyme vaccine.

Third, Europe is a less litigious environment and is largely free of
organized Lyme-patient advocacy groups. In the United States, activists
have turned Lyme disease into everyone's backyard bogeyman. They have
demonized experts for their views on treatment and prevention, and
hired lawyers to successfully argue the dangers of vaccine-induced
autoimmunity (Philadelphia Inquirer B03, July 9 2003).

The activists are already using Internet discussion groups to warn
against a new vaccine. One of them recently wrote "I would encourage
all Lyme patients to consider writing letters, emphasizing the lack of
demand for the last vaccine, and also the fact that any future vaccines
can expect a lack of cooperation, protests, legal quagmires, etc."

A careful, hysteria-free trial of the new OspA vaccine in Europe may
help to undermine the opposition to it in the United States.